Show simple item record

dc.contributor.authorØstnes Hansen, Kine
dc.contributor.authorAndersen, Jeanette hammer
dc.contributor.authorBayer, Annette
dc.contributor.authorPandey, Sunil Kumar
dc.contributor.authorLorentzen, Marianne
dc.contributor.authorJørgensen, Kåre Bredeli
dc.contributor.authorSydnes, Magne Olav
dc.contributor.authorGuttormsen, Yngve
dc.contributor.authorBaumann, Matthias
dc.contributor.authorKoch, Uwe
dc.contributor.authorKlebl, Bert
dc.contributor.authorEickhoff, Jan
dc.contributor.authorHaug, Bengt Erik
dc.contributor.authorIsaksson, Johan
dc.contributor.authorHansen, Espen
dc.date.accessioned2020-02-28T12:26:23Z
dc.date.available2020-02-28T12:26:23Z
dc.date.issued2019-10-24
dc.description.abstractIn this work, we demonstrate that the indole-oxazole-pyrrole framework of the breitfussin family of natural products is a promising scaffold for kinase inhibition. Six new halogenated natural products, breitfussin C–H (3 – 8) were isolated and characterized from the Arctic, marine hydrozoan Thuiaria breitfussi. The structures of two of the new natural products were also confirmed by total synthesis. Two of the breitfussins (3 and 4) were found to selectively inhibit the survival of several cancer cell lines, with the lowest IC50 value of 340 nM measured against the drug-resistant triple negative breast cancer cell line MDA-MB-468, while leaving the majority of the tested cell lines not or significantly less affected. When tested against panels of protein kinases, 3 gave IC50 and Kd values as low as 200 and 390 nM against the PIM1 and DRAK1 kinases, respectively. The activity was confirmed to be mediated through ATP competitive binding in the ATP binding pocket of the kinases. Furthermore, evaluation of potential off-target and toxicological effects, as well as relevant in vitro ADME parameters for 3 revealed that the breitfussin scaffold holds promise for the development of selective kinase inhibitors.en_US
dc.descriptionThis document is the Accepted Manuscript version of a Published Work that appeared in final form in Journal of Medicinal Chemistry, copyright © American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see [insert ACS Articles on Request author-directed link to Published Work, see <a href=https://doi.org/10.1021/acs.jmedchem.9b01006>https://doi.org/10.1021/acs.jmedchem.9b01006. </a>en_US
dc.identifier.citationØstnes Hansen KØH, Andersen Jh, Bayer A, Pandey SK, Lorentzen M, Jørgensen KB, Sydnes MO, Guttormsen Y, Baumann M, Koch, Klebl B, Eickhoff J, Haug BE, Isaksson J, Hansen E. Kinase chemodiversity from the Arctic: the breitfussins. Journal of Medicinal Chemistry. 2019;62(22):10167-10181en_US
dc.identifier.cristinIDFRIDAID 1746797
dc.identifier.doi10.1021/acs.jmedchem.9b01006
dc.identifier.issn0022-2623
dc.identifier.issn1520-4804
dc.identifier.urihttps://hdl.handle.net/10037/17555
dc.language.isoengen_US
dc.publisherAmerican Chemical Societyen_US
dc.relation.journalJournal of Medicinal Chemistry
dc.relation.projectIDNorges forskningsråd: 244264en_US
dc.relation.projectIDNorges forskningsråd: 174885en_US
dc.relation.projectIDinfo:eu-repo/grantAgreement/RCN/SFI/174885/Norway/MabCent - Centre on Marine Bioactives and Drug Discovery//en_US
dc.relation.projectIDinfo:eu-repo/grantAgreement/RCN/BIOTEK2021/244264/Norway/Potent and selective protein kinase inhibitors from the sea//en_US
dc.rights.accessRightsopenAccessen_US
dc.rights.holderCopyright © 2019 American Chemical Societyen_US
dc.subjectVDP::Mathematics and natural science: 400::Chemistry: 440en_US
dc.subjectVDP::Matematikk og Naturvitenskap: 400::Kjemi: 440en_US
dc.titleKinase chemodiversity from the Arctic: the breitfussinsen_US
dc.type.versionacceptedVersionen_US
dc.typeJournal articleen_US
dc.typeTidsskriftartikkelen_US
dc.typePeer revieweden_US


File(s) in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record